FIELD: organic chemistry. SUBSTANCE: product: derivatives of cycloalkylglutaramide of the general formula , where A - (CH2)4; R′ - H, Ru-R4-H, C6H5CH2 and other; Y - unbranched (C1-C3)-alkylene; R2 - H, C6H5 and other, or theirs pharmaceutically acceptable salts. Reagent 1: . Reaction conditions: one or both protective groups are removed (R17 and R18), and any other protective groups in radicals R2 and R3 are also removed following by product isolation or its conversion to the pharmaceutically acceptable salt. EFFECT: improved method of synthesis.
Title |
Year |
Author |
Number |
DERIVATIVES OF CYCLOALKYL-SUBSTITUTED GLUTARIC ACID AMIDE AND PHARMACEUTICAL COMPOSITION BASED ON THEREOF |
1993 |
- Dzhon Kristofer Danilevich[Gb]
- Kejt Dzhejms[Gb]
- Richard Jurek Kobileki[Gb]
|
RU2108322C1 |
1,2,4-TRIAZOLE DERIVATIVES OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS, PHARMACEUTICAL COMPOSITION AND INTERMEDIATE COMPOUNDS |
1992 |
- Rodzher Piter Dikinson[Gb]
- Kennet Richardson[Gb]
|
RU2095358C1 |
METHOD OF SYNTHESIS OF PYRAZOLOPYRIMIDINE COMPOUNDS OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS |
1991 |
- Ehndrju Sajmon Bell[Gb]
- Dehvid Braun[Gb]
- Nikolas Kennet Terrett[Gb]
|
RU2047617C1 |
METHOD OF SYNTHESIS OF TRIAZOLE DERIVATIVES |
1991 |
- Stefen Dzhejms Rehj[Gb]
- Kennet Richardson[Gb]
|
RU2036194C1 |
PYRAZOLOPYRIMIDINONE COMPOUNDS, PHARMACEUTICAL COMPOSITION, METHOD OF TREATMENT |
1991 |
- Ehndrju Simon Bell
- Dehvid Braun
- Nikolas Kennet Terrett
|
RU2114114C1 |
METHOD OF PRODUCING 5-SUBSTITUTED OXAZOLIDINE-2,4-DION |
0 |
|
SU1264841A3 |
INDOLE DERIVATIVES, THEIR OPTICAL ISOMERS AND PHARMACEUTICALLY ACCEPTABLE SALTS |
1991 |
- Dzhon Judzhin Makor[Us]
- Martin Dzhejms Vites[Gb]
|
RU2095360C1 |
SUBSTITUTED PYRAZOLES, PHARMACEUTICAL COMPOSITION BASED ON SAID, METHOD OF PATIENT TREATMENT, INTERMEDIATE COMPOUND |
1993 |
- Dzhen M.Brajt
- Uillard M.Uehlch
|
RU2130453C1 |
METHOD OF PRODUCING POLYPEPTIDE DERIVATIVES OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS |
0 |
- Dzhezit Sing Bindra
- Edvard Foks Klajnman
- Robert Luis Rozati
|
SU1498392A3 |
CRYSTALLINE POLYMORPHOUS FORM OF (S,S,S)-(N-(1-[2-CARBOXY-3- -N-MESYLLYSYLAMINO)PROPYL]-1-CYCLOPENTYLCARBONYL)TYROSINE, METHODS OF ITS SYNTHESIS, INTERMEDIATE COMPOUNDS, PHARMACEUTICAL COMPOSITION AND METHOD OF PATIENT TREATMENT |
1994 |
- Piter Dzhejms Dann
- Majkl Lesli Kh'Juz
|
RU2131869C1 |